A standard model of Alzheimer's disease?

Prion
Lary C WalkerYury O Chernoff

Abstract

The recent Research Framework proposed by the US National Institute on Aging and the Alzheimer's Association (NIA-AA) recommends that Alzheimer's disease be defined by its specific biology rather than by non-specific neurodegenerative and syndromal features. By affirming markers of abnormal Aβ and tau proteins as the essential pathobiological signature of Alzheimer's disease, the Framework tacitly reinforces the amyloid (Aβ) cascade as the leading theory of Alzheimer pathogenesis. In light of recent evidence that the cascade is driven by the misfolding and templated aggregation of Aβ and tau, we believe that an empirically grounded Standard Model of Alzheimer's pathogenesis is within reach. A Standard Model can clarify and consolidate existing information, contextualize risk factors and the complex disease phenotype, identify testable hypotheses for future research, and pave the most direct path to effective prevention and treatment.

References

Apr 10, 1992·Science·J A Hardy, G A Higgins
May 23, 2006·Current Topics in Medicinal Chemistry·Susan M CatalanoGene G Kinney
Jan 25, 2007·Nature Reviews. Molecular Cell Biology·Christian Haass, Dennis J Selkoe
Apr 8, 2011·Science Translational Medicine·David M HoltzmanAlison M Goate
Oct 6, 2011·Journal of Alzheimer's Disease : JAD·Eric M ReimanPierre N Tariot
Aug 9, 2013·Acta Neuropathologica·David M A Mann, John Hardy
Aug 13, 2013·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Michael W WeinerUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 21, 2013·Acta Neuropathologica·Johannes Attems, Kurt A Jellinger
Aug 29, 2013·Acta Neuropathologica·Heiko Braak, Kelly Del Tredici
Nov 28, 2013·Annual Review of Genetics·Stanley B Prusiner
Dec 3, 2013·Alzheimer's Research & Therapy·Eric Y Hayden, David B Teplow
Dec 24, 2013·Neuron·Clifford R Jack, David M Holtzman
Mar 22, 2014·Science Translational Medicine·Reisa A SperlingPaul Aisen
Nov 20, 2014·Molecular Neurodegeneration·Ilie-Cosmin StancuIlse Dewachter
May 27, 2015·Nature Neuroscience·Erik S Musiek, David M Holtzman
Mar 31, 2016·EMBO Molecular Medicine·Dennis J Selkoe, John Hardy
Jul 28, 2016·Philosophical Transactions. Series A, Mathematical, Physical, and Engineering Sciences·J M Butterworth
Sep 2, 2016·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Randall J BatemanUNKNOWN DIAN-TU Pharma Consortium for the Dominantly Inherited Alzheimer Network
Nov 29, 2016·Annual Review of Genetics·Lary C Walker
Jan 18, 2017·Cold Spring Harbor Perspectives in Medicine·Joel C Watts, Stanley B Prusiner
Feb 28, 2017·Lancet Neurology·Barbara E Stopschinski, Marc I Diamond
Apr 15, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Clifford R JackUNKNOWN Contributors
Jul 7, 2018·Chemical Communications : Chem Comm·Mattias TörnquistSara Linse

❮ Previous
Next ❯

Citations

Sep 22, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tatiana A ChernovaKeith D Wilkinson
Aug 24, 2019·Current Alzheimer Research·Jessica Sarahi Alavez-Rubio, Teresa Juarez-Cedillo
Oct 14, 2020·PLoS Computational Biology·Travis B ThompsonUNKNOWN Alzheimer’s Disease Neuroimaging Initiative
Jun 25, 2021·Chemical Science·Junjun TanDavid G Lynn

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aging Genetics (Keystone)

This feed focuses on aging epidemiology and genetic, epigenetic, and proteomic aspects underlying aging, as well as aging- associated biomarkers. Here the latest research in this domain.

Cell Aging (Keystone)

This feed focuses on cellular aging with emphasis on the mitochondria, autophagy, and metabolic processes associated with aging and longevity. Here is the latest research on cell aging.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Related Papers

Molecular and Cellular Neurosciences
Ann D CohenHenrik Zetterberg
Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Ara S KhachaturianZaven S Khachaturian
International Journal of Molecular Sciences
Anne Claire KimYun Kyung Kim
© 2022 Meta ULC. All rights reserved